Search Results - "Gorsline, Jane"

  • Showing 1 - 18 results of 18
Refine Results
  1. 1

    Illicit gamma-hydroxybutyrate (GHB) and pharmaceutical sodium oxybate (Xyrem® ): Differences in characteristics and misuse by Carter, Lawrence P, Pardi, Daniel, Gorsline, Jane, Griffiths, Roland R

    Published in Drug and alcohol dependence (01-09-2009)
    “…Abstract There are distinct differences in the accessibility, purity, dosing, and misuse associated with illicit gamma-hydroxybutyrate (GHB) compared to…”
    Get full text
    Journal Article
  2. 2

    Steady-state pharmacokinetics and dose relationship of nicotine delivered from Nicoderm (Nicotine Transdermal System) by Gorsline, J, Gupta, S K, Dye, D, Rolf, C N

    Published in Journal of clinical pharmacology (01-02-1993)
    “…An open-label, randomized, crossover study determined nicotine pharmacokinetics at steady state of a new Nicotine Transdermal System in 24 healthy adult male…”
    Get more information
    Journal Article
  3. 3

    Comparison of the nicotine pharmacokinetics of Nicoderm (nicotine transdermal system) and half-hourly cigarette smoking by Gupta, S K, Hwang, S S, Causey, D, Rolf, C N, Gorsline, J

    Published in Journal of clinical pharmacology (01-10-1995)
    “…Nicoderm, a nicotine transdermal system (NTS), provides a continuous, transdermal delivery of nicotine and is used as an aid to smoking cessation. In contrast,…”
    Get more information
    Journal Article
  4. 4

    Review: Illicit Gamma-Hydroxybutyrate (GHB) and Pharmaceutical Sodium Oxybate (Xyrem): Differences in Characteristics and Misuse by Carter, Lawrence P, Pardi, Daniel, Gorsline, Jane, Griffiths, Roland R

    Published in Drug and alcohol dependence (01-09-2009)
    “…There are distinct differences in the accessibility, purity, dosing, and misuse associated with illicit gamma-hydroxybutyrate (GHB) compared to pharmaceutical…”
    Get full text
    Journal Article
  5. 5

    Real-world efficacy of prescription and over-the-counter nicotine replacement therapy by Shiffman, Saul, Rolf, Clyde N., Hellebusch, Stephen J., Gorsline, Jane, Gorodetzky, Charles W., Chiang, Yu-Kun, Schleusener, Debra S., Marino, Michael E. Di

    Published in Addiction (Abingdon, England) (01-05-2002)
    “…ABSTRACT Aims To assess smoking cessation rates achieved with nicotine gum and patch in simulated over‐the‐counter (OTC) and actual prescription (Rx) settings…”
    Get full text
    Journal Article
  6. 6

    Efficacy of over-the-counter nicotine patch by Shiffman, Saul, Gorsline, Jane, Gorodetzky, Charles W.

    Published in Nicotine & tobacco research (01-11-2002)
    “…This study aimed to assess the efficacy of the nicotine patch for smoking cessation, under simulated conditions of over-the-counter sale, absent any direct…”
    Get full text
    Journal Article
  7. 7

    Triamcinolone acetonide 21-oic acid methyl ester: a potent local antiinflammatory steroid without detectable systemic effects by Gorsline, J, Bradlow, H L, Sherman, M R

    Published in Endocrinology (Philadelphia) (01-01-1985)
    “…There have been many previous attempts to prepare glucocorticoid analogs that would have high antiinflammatory activity at the site of application but minimal…”
    Get more information
    Journal Article
  8. 8

    Avian endocrine responses to environmental pollutants by Rattner, B A, Eroschenko, V P, Fox, G A, Fry, D M, Gorsline, J

    Published in The Journal of experimental zoology (01-12-1984)
    “…Many environmental contaminants are hazardous to populations of wild birds. Chlorinated hydrocarbon pesticides and industrial pollutants are thought to be…”
    Get more information
    Journal Article
  9. 9

    In vitro and in vivo evaluation of a once-daily controlled-release pseudoephedrine product by Hwang, S S, Gorsline, J, Louie, J, Dye, D, Guinta, D, Hamel, L

    Published in Journal of clinical pharmacology (01-03-1995)
    “…The functionality of a once-daily, osmotic dosage form--gastrointestinal therapeutic system (pseudoephedrine HCl) or GITS (PeHCl)--was studied in vitro and in…”
    Get more information
    Journal Article
  10. 10

    Comparison of the pharmacokinetics of two nicotine transdermal systems: nicoderm and habitrol by Gupta, S K, Okerholm, R A, Eller, M, Wei, G, Rolf, C N, Gorsline, J

    Published in Journal of clinical pharmacology (01-05-1995)
    “…This randomized, crossover study compared the nicotine and cotinine pharmacokinetic parameters and plasma concentration profiles of two different nicotine…”
    Get more information
    Journal Article
  11. 11

    Absorption and adverse effects following topical and oral administration of three transdermal nicotine products to dogs by Matsushima, D, Prevo, M E, Gorsline, J

    Published in Journal of pharmaceutical sciences (01-03-1995)
    “…To evaluate potential adverse effects from inadvertent exposure to a nicotine transdermal system or "patch", three marketed products were administered…”
    Get more information
    Journal Article
  12. 12

    Nicotine pharmacokinetics of Nicoderm (nicotine transdermal system) in women and obese men compared with normal-sized men by Prather, R D, Tu, T G, Rolf, C N, Gorsline, J

    Published in Journal of clinical pharmacology (01-07-1993)
    “…This study examined the effect of gender and body weight on the pharmacokinetic properties of the Nicotine Transdermal System (NTS) (Nicoderm). This NTS was…”
    Get more information
    Journal Article
  13. 13

    Single- and multiple-dose pharmacokinetics of Nicoderm (Nicotine Transdermal System) by Gupta, S K, Okerholm, R A, Coen, P, Prather, R D, Gorsline, J

    Published in Journal of clinical pharmacology (01-02-1993)
    “…The pharmacokinetics and tolerability of single and multiple applications of Nicotine Transdermal Systems (NTS), designed to deliver 14 mg of nicotine per 24…”
    Get more information
    Journal Article
  14. 14

    Comparison of plasma nicotine concentrations after application of nicoderm (nicotine transdermal system) to different skin sites by Gorsline, J, Okerholm, R A, Rolf, C N, Moos, C D, Hwang, S S

    Published in Journal of clinical pharmacology (01-06-1992)
    “…Drug absorption through the skin can vary according to the application site. The nicotine transdermal system, Nicoderm (Alza Corp., Palo Alto, CA) contains a…”
    Get more information
    Journal Article
  15. 15

    Effects of adrenalectomy and spironolactone on urinary metabolites of aldosterone in rats by Gorsline, J, Morris, D J

    Published in Steroids (01-01-1988)
    “…The quantities and temporal sequences of appearance of aldosterone metabolites in the urine of adrenalectomized rats, and adrenalectomized rats treated with…”
    Get more information
    Journal Article
  16. 16

    The hypertensinogenic activity of 19-nor-deoxycorticosterone in the adrenalectomized spontaneously hypertensive rat by Gorsline, J, Morris, D J

    Published in Journal of steroid biochemistry (01-10-1985)
    “…Infusions of 10 or 25 micrograms/day 19-nor-DOC for 2 weeks in adrenalectomized spontaneously hypertensive rats led to significant increases in blood pressure,…”
    Get more information
    Journal Article
  17. 17

    Hypertensinogenic Activities of Ring A-Reduced Metabolites of Aldosterone by GORSLINE, JANE, HARNIK, MARCEL, TRESCO, PATRICK A, MORRIS, DAVID J

    Published in Hypertension (Dallas, Tex. 1979) (01-04-1986)
    “…Spontaneously hypertensive rats (SHR) were adrenalectomized at 6 weeks of age and received subcutaneous implants of mini-osmotic pumps, loaded with vehicle…”
    Get full text
    Journal Article
  18. 18

    The effects of 19-nor-aldosterone on blood pressure of adrenalectomized spontaneously hypertensive rats by Morris, D J, Gorsline, J, Tresco, P A, Harnik, M

    Published in Steroids (01-12-1985)
    “…The relative hypertensinogenic potencies of recently synthesized 19-nor-aldosterone and its precursor 19-OH-aldosterone were assessed in comparison to that of…”
    Get more information
    Journal Article